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Background: Free radical activity is an important cause of vascular complications in type 1 diabetes
mellitus. But data regarding vascular complications in type 2 diabetes mellitus are scant.
Objectives: The aim of this study was to examine free radical activity in type 2 diabetic patients with
hypertension compared to those without hypertension.
Materials and Methods: The serum levels of lipid peroxidation product, MDA malondialdehyde), the free
radical scavenger, SOD (superoxide dismutase) and NO (nitric oxide) were studied in 50 type 2 diabetic
outpatients. Controls were regarded as those diabetic outpatients who did not have hypertension.
Result: Among 50 patients thus studied 19 were hypertensive. The concentration (median (range)) of
both SOD (21.31(5.33–26.64) vs. 16.65(6.66–22.64) U/dl; p < 0.05) and NO (18.54 (11.40–37.07) vs.
21.39(15.69–35.65) U/dl; p < 0.05) were reduced in the hypertensive group. Similarly, concentration
(median (range) of MDA (359(231–718) vs. 385(256–666) lmoles/dl; p < 0.01 were increased in the
hypertensive group.
Conclusion: The reduction in serum levels of SOD and NO with a concomitant increase in serum MDA
levels is consistent with an increase in free radical activity in hypertensive type 2 diabetics.
 2010 International Journal of Diabetes Mellitus. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.1. Introduction
Free radical activity has been implicated in the development of
diabetic vascular complications in type 1 diabetes mellitus. It plays
an important role in both microvascular and macrovascular com-
plications in diabetes mellitus. However, data regarding vascular
complications in type 2 diabetes mellitus are scant. Cardiovascular
diseases (CVD) are the major causes of mortality in persons with
diabetes, and many factors including hypertension contribute to
this high prevalence of CVD. Hypertension is twice as frequent in
patients with diabetes compared with patients without the
disease. Furthermore, up to 75% of CVD in diabetes may be
attributable to hypertension, leading to recommendations for
more aggressive treatment for those having hypertension in this
disease [1].
Long-term complications of diabetes are supposed to be, at least
in part, mediated by increased free radical generation and subse-
quent oxidative stress. In this study, we have attempted to summa-
rize the experimental evidence in this ﬁeld, and to emphasize the
possible importance of oxidative stress in the development of dia-
betic vascular complications.
Free radicals may be deﬁned as any chemical species that con-
tains unpaired electrons. Unpaired electrons increase the chemicalellitus. Published by Elsevier Ltd.
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Oreactivity of an atom or a molecule. Common examples of free rad-
icals include the hydroxyl radical (0H), super oxide anion (02),
transition metals, such as iron (Fe), copper (Cu), nitric oxide (NO)
and peroxynitrite (OONO) [2]. Free radicals and reactive nonradi-
cal species derived from radicals exist in biological cells and tissues
at very low concentrations [3,4]. Halliwell and Gutteridge [3] have
deﬁned antioxidants as substances that are able, at relatively low
concentrations, to compete with other oxidizable substrates, and
thus, to signiﬁcantly delay or inhibit the oxidation of these sub-
strates. This deﬁnition includes the enzymes SOD, glutathione per-
oxidase (GPx) and catalase, as well as nonenzymatic compounds
such as tocopherol (vitamin E), b-carotene, ascorbic acid (vitamin
C), and glutathione, which scavenge the reactive oxygen species.
2. Materials and methods
The aim of this study was to investigate whether the serum lev-
els of lipid peroxidation product, malondialdehyde (MDA), serum
superoxide dismutase (SOD) and serum nitric oxide (NO) were al-
tered in normotensive type 2 diabetic patients and type 2 diabetic
patients who subsequently developed hypertension.
We selected 50 type 2 diabetic patients. 19 of these type 2 dia-
betic patients had subsequently developed hypertension. The crite-
ria for hypertension were a mean arterial pressure of greater than
the upper range of accepted normal pressure, and a mean arterial
pressure of greater than 110 mm of Hg (normal is 90 mm of Hg)
that is considered to be hypertensive.pen access under CC BY-NC-ND license.
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hypertensive state by measuring their blood pressure, three times
a day for a period of one week, and the average was taken for the
evaluation of blood (mean arterial blood pressure = 1/3 of pulse
pressure + diastolic pressure). Blood pressure was measured in
the supine position, manually in both arms, by a calibrated
sphygmomanometer.
Subjects underwent a medical history screening, a physical
examination and laboratory analysis, which included CBC, serum
electrolytes, blood urea, creatinine, fasting blood glucose and HbAc
1, ECG, and echocardiography.
Exclusion criteria included tobacco, caffeine use, cardiac and
pulmonary disease and evidence of left ventricular hypertrophy.
The hypertensive patients were on calcium channel blockers. All
medications were stopped 12 h before blood sample collection.
In the morning fasting blood sample was taken. Venous blood
was collected from the anterior aspect of the forearm with the help
of disposable syringes. Serumwas separated within 1 h after refrig-
eration. The straw colored supernatant serum was centrifuged and
separated. All three tests were carried out within 2 h, after obtain-
ing venous blood.
The method of testing for MDA (malondialdehyde) as a marker
of lipid peroxidation product was that of determined through the
method of Okhawa et al. (1974) who measured MDA as thiobarbi-
turic acid reactive substances (TBARS) [5]. Superoxide dismutase
was assessed by the method of Kakkar et al. [6]. Nitric oxide was
assessed through the method of Green et al. [7]. In this method, ni-
tric oxide in serum was estimated indirectly by measuring the
amount of nitrates formed from nitric oxide.
3. Observation and results
These results are consistent with a signiﬁcant increase in free
radical activity in type 2 diabetic patients with coexistent hyper-
tension. The SOD and NO levels were signiﬁcantly decreased and
MDA levels were signiﬁcantly increased in those type 2 diabetic
patients who had coexistent hypertension (Table 1).
4. Discussion
Increased concentrations of oxygen-derived free radicals are
implicated in the pathogenesis of vascular complications in diabe-
tes. Superoxide anion appears to block endothelium derived nitric
oxide mediated relaxation by inactivating the eNOS. In a hypergly-
cemic state, the production of superoxide is stimulated, and the en-Table 1
Clinical and Laboratory data of diabetic patients without hypertension a
Parameters Controls
Number 31
Sex (M/F) 24/7
Age (In years) 54 (35–65)
Wt. (kg) 54 (40–70)
Duration of diabetes (years) 4 (0A–14)
Fasting plasma glucose (mg/dl) 175 ± 67
Glycosylated Haemoglobin (%) 9.6 ± 1.7
Mean arterial pressure (mmHg) 97 ± 2
MDA (moles/dl) 359 (231–718) p < 0.01
SOD UB/dl 21.31 (5.33–26.64) SD ±
NO (U/dl) 18.54 (11.40–37.07) SD
Median (Range), SOD, superoxide dismutase, NO, nitric oxide; MDA, m
A, newly diagnosed type 2 diabetic patients.
B, one unit of enzyme is deﬁned as enzyme concentration required t
1 min.
Table 1 shows the clinical and biochemical details of the study groups
duration of diabetes between the two study groups. Patients with hyp
glycosylated hemoglobin levels (p < 0.001) compared to those withoutzyme superoxide dismutase is inhibited by non-enzymatic
glycosylation known as Maillard reaction [8]. Glycation was shown
to affect the C-terminal end of the enzyme, reducing its heparin
binding afﬁnity. Thus, protection against extra cellular radicals
by cell surface attached SOD may be impaired in diabetes leaving
the endothelial cell susceptible to damage by super oxide anion.
The addition of exogenous SOD restores normal or unmasks even
greater acetylcholine induced relaxation in diabetic aorta. Thus,
in diabetic conditions, normal levels of antioxidant enzymes may
be insufﬁcient or may be functionally impaired, so as to preserve
a physiological contractile response [9].
Nitric oxide and superoxide anion readily react to form perox-
ynitrite (OONO) at nearly diffusion limited rate. During physiologic
conditions O2 scavengers and formation of OONO are minimal.
During pathologic conditions such as in the presence of increased
concentrations of O2 or after O2 scavengers are exhausted, signif-
icant concentrations of OONOmay be produced. Peroxynitrite di-
rectly causes oxidation, peroxidation, and nitration of biologically
important molecules (e.g. lipids protein and DNA). It is more cyto-
toxic than NO in a variety of experimental conditions [10].
An important example of a reaction caused by OONO is the
nitration of tyrosine. Tyrosine nitration inhibits tyrosine phosphor-
ylation, alters the dynamics of assembly and disassembly of cyto-
skeletal proteins, and inhibits tyrosine hydroxylase, thereby
inhibiting the cycloskeletal movements of endothelial cells [10].
Nitric oxide has contrasting effects on lipids, particularly on oxi-
dation of LDL lipoproteins in the pathogenesis of atherosclerotic le-
sions. NO inhibits lipid peroxidation by inhibiting radical chain
propagation, reactions via radical reaction with lipid peroxyl and
alkoxyl group. As a ligand to iron (and other transition metals),
NO modulates the peroxidant effects of iron and thereby limits
the formation of hydroxyl radicals and iron dependent electron
transfer reactions. NO inhibits all and OONOmediated lipoprotein
oxidation in macrophage and endothelial cell systems. However,
NO, induced OONO formation can oxidize low density lipopro-
teins to potentially atherogenic species. In summary, OONO is
more cytotoxic than NO in a variety of experimental systems and
the balance of NO, O2, and OONO, scavenging systems determine
whether biologically relevant OONO concentrations will occur in
tissues. Thus, the endothelium appears to modulate vascular func-
tions by releasing relaxant substances like NO and constrictor sub-
stances like superoxide. Superoxide may play a key role in the
relationship between cardiovascular diseases and metabolic disor-
ders like diabetes mellitus, and will almost certainly prove to be a
focus for future therapies [10].s control/diabetic patients with hypertension.
Hypertensives
19
15/4
51 (40–71)
52 (40–71)
3 (0–20)
223± 84 p < 0.001
11 ± 2.8 p < 0.001
116 ± 6 p < 0.05
, SD ± 55.85 385 (256–666), SD ± 63.34
4.64 16.65 (6.66–22.64) SD ± 4.08 p < 0.05
+ 4.34 21.39 (15.69–35.65) SD ± 4.79 p < 0.05,
alondialdehdye.
o inhibit the optical density of chromogen production by 50% in
. There were no signiﬁcant differences in the age, weight, sex, and
ertension had higher plasma fasting glucose levels (p < 0.001) and
hypertension.
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Much evidence suggests that free radical over generation may
be considered the key in the generation of insulin resistance, dia-
betes and cardiovascular disease. Many new speciﬁc causal antiox-
idants are being developed [10,11], and may become important
tools in opposing the increasing epidemic of diabetes a real emer-
gency in our future. It has been demonstrated that insulin resis-
tance is associated in humans with reduced intracellular
antioxidant defense [12], and that diabetic subjects prone to com-
plications may have a defective intracellular antioxidant response
[13,14] where what we call genetic predisposition to diabetes, as
well as liability to its late complications, might be based on a deﬁ-
cient ROS-scavenging ability in b-cells and/or in target tissues such
as endothelium.
Oxidative stress is involved in various cardiovascular diseases,
including atherosclerosis, hypertension and the aging process;
therefore, therapeutic strategies to modulate this maladaptive re-
sponse should become a target for future extensive investigation,
and could have a broad application [15].
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